Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.

MLA

Pichiorri, Flavia, et al. “Preclinical Assessment of FHIT Gene Replacement Therapy in Human Leukemia Using a Chimeric Adenovirus, Ad5/F35.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 12, no. 11 Pt 1, June 2006, pp. 3494–501. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-05-2581.

APA

Pichiorri, F., Trapasso, F., Palumbo, T., Aqeilan, R. I., Drusco, A., Blaser, B. W., Iliopoulos, D., Caligiuri, M. A., Huebner, K., & Croce, C. M. (2006). Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 12(11 Pt 1), 3494–3501. https://doi.org/10.1158/1078-0432.CCR-05-2581

Chicago

Pichiorri, Flavia, Francesco Trapasso, Tiziana Palumbo, Rami I Aqeilan, Alessandra Drusco, Bradley W Blaser, Dimitrios Iliopoulos, Michael A Caligiuri, Kay Huebner, and Carlo M Croce. 2006. “Preclinical Assessment of FHIT Gene Replacement Therapy in Human Leukemia Using a Chimeric Adenovirus, Ad5/F35.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 12 (11 Pt 1): 3494–3501. doi:10.1158/1078-0432.CCR-05-2581.